Ira M. Jacobson, MD, FACG
From Hepatitis C to COVID-19: Can We Triumph Again?

Wednesday, October 28 | 3:00 pm – 3:30 pm | Virtual ACG 2020 Meeting Platform

Dr. Jacobson

In the David Y. Graham Distinguished Lecture, Dr. Ira Jacobson will compare and contrast the development of therapeutic regimens for two RNA viruses, HCV and SARS-CoV-2, and use those lessons to understand the latest developments in therapy for COVID-19 as well as emerging treatments and the vaccine development process.

Ira M. Jacobson, MD, FACG, is Director of Hepatology at New York University Langone Health. Previously, he served as Chief of the Division of Gastroenterology and Hepatology and Vincent Astor Distinguished Professor of Medicine and Medical Director of the Center for the Study of Hepatitis C at Weill Cornell Medical College and New York Presbyterian Hospital, as well as Chair of Medicine at Mount Sinai Beth Israel Medical Center. Dr. Jacobson is a Fellow of the ACG, ACP, and AGA, and a member of AASLD and EASL. In addition to an active practice with a focus on patients with liver disease, he has been an investigator in many trials for hepatitis B and C treatment, serving as Principal Investigator and author of many trials involving novel treatments, with a clinical research focus on hepatitis B and NAFLD. He served on the Gastroenterology and Transplant Hepatology Examination Committees of the ABIM and was Associate Editor of the Journal of Hepatology, and co-chaired the annual Viral Hepatitis Congress in Frankfurt, Germany. He has authored or coauthored over 250 peer-reviewed papers, chapters, and reviews in NEJM, Lancet, Gastroenterology, Hepatology, Journal of Hepatology, Journal of Viral Hepatitis, Clinical Gastroenterology and Hepatology, and more. He also edited two books on ERCP and a volume on hepatitis B for Clinics in Liver Disease. Dr. Jacobson earned his medical degree from Columbia University College of Physicians and Surgeons. After completing an internship and residency at the University of California San Francisco, he trained as a fellow in gastroenterology at Massachusetts General Hospital.

The Graham Lecturer is chosen by the ACG President and is subject to approval by the ACG Board of Trustees. Established in 2004 in recognition of the many contributions to clinical gastroenterology made by David Y. Graham, MD, MACG, this named lectureship was made possible through a donation by Otsuka Pharmaceutical Co., Inc., and Meretek Diagnostics, Inc.